Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.4
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 30016727
Zhang N, et al. (2018) cPKC╬│ alleviates ischemic injury through modulating synapsin Ia/b phosphorylation in neurons of mice. Brain Res Bull 142, 156-162 30016727
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S9-p - SYN1 (mouse)
Modsite: NYLRRRLsDsNFMAN SwissProt Entrez-Gene
Orthologous residues
SYN1 (human): S9‑p, SYN1 iso2 (human): S9‑p, SYN1 (mouse): S9‑p, SYN1 iso1 (mouse): S9‑p, SYN1 iso3 (mouse): S9‑p, SYN1 (rat): S9‑p, SYN1 (cow): S9‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  neuron-'brain, cerebral cortex'
Cellular systems studied:  primary cultured cells
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
deoxygenation, ischemia/reperfusion no change compared to control

S62-p - SYN1 (mouse)
Modsite: stAAPVAsPAAPsPG SwissProt Entrez-Gene
Orthologous residues
SYN1 (human): S62‑p, SYN1 iso2 (human): S62‑p, SYN1 (mouse): S62‑p, SYN1 iso1 (mouse): S62‑p, SYN1 iso3 (mouse): S62‑p, SYN1 (rat): S62‑p, SYN1 (cow): S62‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  neuron-'brain, cerebral cortex'
Cellular systems studied:  primary cultured cells
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
deoxygenation, ischemia/reperfusion no change compared to control

S551-p - SYN1 (mouse)
Modsite: PAArPPAsPsPQrQA SwissProt Entrez-Gene
Orthologous residues
SYN1 (human): S551‑p, SYN1 iso2 (human): S551‑p, SYN1 (mouse): S551‑p, SYN1 iso1 (mouse): S551‑p, SYN1 iso3 (mouse): S551‑p, SYN1 (rat): S549‑p, SYN1 (cow): S551‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  neuron-'brain, cerebral cortex'
Cellular systems studied:  primary cultured cells
Species studied:  mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKCG (human) co-immunoprecipitation, genetic knockout/knockin of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
deoxygenation, ischemia/reperfusion decrease
Downstream Regulation
Effect of modification (process):  cytoskeletal reorganization
Comments:  OGD induces morphological damage of neurites in cortical neurons; protects against ischemic injury and cell death

S553-p - SYN1 (mouse)
Modsite: ArPPAsPsPQrQAGA SwissProt Entrez-Gene
Orthologous residues
SYN1 (human): S553‑p, SYN1 iso2 (human): S553‑p, SYN1 (mouse): S553‑p, SYN1 iso1 (mouse): S553‑p, SYN1 iso3 (mouse): S553‑p, SYN1 (rat): S551‑p, SYN1 (cow): S553‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  neuron-'brain, cerebral cortex'
Cellular systems studied:  primary cultured cells
Species studied:  mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKCG (human) co-immunoprecipitation, genetic knockout/knockin of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
deoxygenation, ischemia/reperfusion decrease
Downstream Regulation
Effect of modification (process):  cytoskeletal reorganization
Comments:  OGD induces morphological damage of neurites in cortical neurons; protects against ischemic injury and cell death

S605-p - SYN1 (mouse)
Modsite: AGPtRQAsQAGPGPr SwissProt Entrez-Gene
Orthologous residues
SYN1 (human): S605‑p, SYN1 iso2 (human): S605‑p, SYN1 (mouse): S605‑p, SYN1 iso1 (mouse): S605‑p, SYN1 iso3 (mouse): S577‑p, SYN1 (rat): S603‑p, SYN1 (cow): S605‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  neuron-'brain, cerebral cortex'
Cellular systems studied:  primary cultured cells
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
deoxygenation, ischemia/reperfusion no change compared to control